Home » Topics » BioWorld Science

BioWorld Science
RSS

China's NMPA clears initiation of phase III trial of socazolimab for ES-SCLC

March 9, 2021

Collagen means well in pancreatic cancer

March 9, 2021

Macrophages dampen neuropathic pain

March 9, 2021

Chimerix opens enrollment in phase III study of dociparstat for AML

March 9, 2021

Seres discontinues enrollment in MCGRAW study of SER-401 in metastatic melanoma

March 8, 2021

Bavarian Nordic reports preclinical data on COVID-19 vaccine candidate ABNCoV2

March 8, 2021

REGN1908-1909 ameliorates bronchoconstriction in patients with cat-allergy asthma

March 8, 2021

Roche withdraws Tecentriq U.S. indication for prior-platinum treated metastatic urothelial carcinoma

March 8, 2021

Abivax stops phase IIb/III trial of ABX-464 in high-risk COVID-19 based on DSMB recommendation

March 8, 2021

FDA grants accelerated approval to Yescarta for relapsed or refractory follicular lymphoma

March 8, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...